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Abstract Objective: Risk adjustment
systems now in use were developed
more than a decade ago and lack
prognostic performance. Objective of
the SAPS 3 study was to collect data
about risk factors and outcomes in a
heterogeneous cohort of intensive
care unit (ICU) patients, in order to
develop a new, improved model for
risk adjustment. Design: Prospective
multicentre, multinational cohort
study. Patients and setting: A total of
19,577 patients consecutively admit-
ted to 307 ICUs from 14 October to
15 December 2002. Measurements
and results: Data were collected at
ICU admission, on days 1, 2 and 3,
and the last day of the ICU stay. Data
included sociodemographics, chronic
conditions, diagnostic information,
physiological derangement at ICU
admission, number and severity of
organ dysfunctions, length of ICU
and hospital stay, and vital status at
ICU and hospital discharge. Data re-
liability was tested with use of kappa
statistics and intraclass-correlation
coefficients, which were >0.85 for
the majority of variables. Complete-
ness of the data was also satisfactory,
with 1 [0–3] SAPS II parameter
missing per patient. Prognostic per-
formance of the SAPS II was poor,
with significant differences between
observed and expected mortality rates
for the overall cohort and four (of
seven) defined regions, and poor
calibration for most tested subgroups.
Conclusions: The SAPS 3 study was
able to provide a high-quality multi-
national database, reflecting hetero-
geneity of current ICU case-mix and
typology. The poor performance of
SAPS II in this cohort underscores
the need for development of a new
risk adjustment system for critically
ill patients.
Keywords Intensive care unit ·
Severity of illness · ICU mortality ·
Hospital mortality · Risk adjustment1337
Introduction
Following the publication in the early 1980s of the Acute
Physiology and Chronic Health Evaluation Score
(APACHE [1]), Simplified Acute Physiology Score
(SAPS [2]), and-some years later—APACHE II [3] sys-
tems, outcome prediction became an important topic
among European intensivists. Ten years later, a new
generation of these instruments was published: APACHE
III [4], SAPS II [5], and Mortality Probability Model
(MPM) II [6]. All of these newer systems were developed
by using sophisticated statistical techniques in large
multinational databases, and were found to perform better
than their predecessors [7, 8].
The availability of such sophisticated methods for risk
adjustment facilitated outcome research in critically ill
patients, which became increasingly important over time.
Risk adjustment systems now have a fixed place in crit-
ical care research for various purposes. At the patient
level, the reporting of severity of illness and the use of
risk-adjusted mortality rates to draw inferences from their
results are a prerequisite for any study to be published. At
the intensive care unit (ICU) level, observed-to-expected
mortality ratios (or the use of direct standardisation
techniques based on severity scores) have become stan-
dard for assessing the impact of ICU-related factors on
outcome, such as the effects of organisation and man-
agement [9, 10].
However, a series of studies assessing the performance
of risk adjustment systems unveiled a lack of prognostic
performance of these systems: In most cases, lack of
calibration was evident over several subgroups of pa-
tients, often accompanied by an underestimation of mor-
tality in low-risk patients and an overestimation in high-
risk patients. This pattern was observed for all published
outcome prediction models in several countries [11, 12,
13, 14, 15, 16, 17, 18] and seemed to be worsening over
time [19].
For this reason, several researchers tried to improve
the prognostic performance of various systems through
recalibration, using one of two possible approaches. A
level 1 customization requires calculation of a new
equation for the prediction of hospital mortality (without
changing the weights of the constituent variables). A level
2 customization involves a reweighting of each variable
contained in the model. Although recalibration was able
to improve prognostic accuracy in some cases [13, 14], it
generally did not solve the various problems inherent in
the models.
These problems can be classified as either user-, pa-
tient-, or model-dependent. User-dependent problems in-
clude differences in the definitions and application crite-
ria [20, 21]. Patient-dependent problems are mainly shifts
in the baseline characteristics of the populations over time
[22]: age distribution, distribution of illnesses, and the
development of new treatments, all of which affect
prognosis. Model-dependent problems have many differ-
ent causes, such as the lack of important prognostic
variables (e.g., diagnostic information [4, 23]) or the
presence, location and aetiology of infection [24, 25, 26].
Confounding variables and statistically wrong assump-
tions [9, 27] also distort performance results.
If recalibration is not sufficient to improve the per-
formance of the prognostic model, the only alternative is
to develop a new model that takes into account the results
of studies done since the original model was developed.
This means incorporating missing variables that have
been shown to affect outcome, minimizing problems with
the application of the model, and reducing the possibility
of other confounders.
The objective of the SAPS 3 project was to cope with
the above-stated problems by developing a new model for
improved risk adjustment in critically ill patients. Another
important goal was to make the new model available free
of charge for use in the scientific community.
In the SAPS 3 study (which took place at the end of
2002), data about risk factors and outcomes in an inter-
national multicentric cohort of critically ill patients were
prospectively collected so that a high-quality database
would be available for further analysis of the associations
between risks and outcomes in our patients.
Materials and methods
Project Organization
The SAPS 3 project was conducted by the SAPS 3 Outcomes Re-
search Group. The project was endorsed by the European Society
for Intensive Care Medicine (ESICM, http://www.esicm.org) and
conducted in cooperation with the Section on Health Services Re-
search and Outcome of the ESICM. The SAPS 3 Outcomes Re-
search Group consists of a project coordinator and a steering group.
The steering group was responsible for the scientific conduct and
consistency of the project. An additional advisory board integrated
further scientists with special expertise who were asked for com-
ments on the scientific content and for help in conducting the
project. The complete board lists can be found in Appendix D of the
Electronic Supplementary Material (ESM).
During the data collection phase, a coordination and commu-
nications centre (CCC) was installed. The CCC was responsible for
the management and control of the project. This included the ad-
ministration of all project tasks and implementation of actions and
activities as necessary; communication between project partners
(e.g., centres, researchers and institutions) through sampling and
distribution of necessary information; and pooling and adminis-
tration of the data provided by project participants. In addition, the
CCC provided almost around-the-clock service to answer urgent
questions and resolve problems during the phase of data collection.
In each country, a country coordinator was responsible for op-
erational management and direct communication with the partici-
pating ICUs in that country, including giving specific help when
necessary. The country coordinator was responsible for ensuring
completion of the various tasks required of the participating ICUs.
The list of country coordinators can be found in Appendix E of the
ESM.
At the ICU level, an ICU coordinator was responsible for local
activities, such as obtaining approval from the local ethics or data-1338
protection committees where applicable. In addition, the ICU co-
ordinator was responsible for supervising the daily data collection,
problem management, controlling the completeness of the data,
data quality control, training medical and nonmedical staff for data
collection, management of the data, and transmission of the data to
the CCC or country coordinator. The list of ICU coordinators can
be found in Appendix F of the ESM.
Data collection
Patient data were recorded by using either online data collection
software (provided by iMDsoft, Tel Aviv, Israel) or the SAPS 3
stand-alone database system (provided by the CCC). The latter
software used a Microsoft Access database (Microsoft Corporation,
Redmond, WA, USA) for data storage and needed no Internet
connection for data entry. Both systems maintained a variety of
plausibility controls to ensure the quality of the recorded data. Each
variable was precisely defined before the start of data collection
(see Appendix C of the ESM). Detailed definitions of the variables
were available to participants in both paper and electronic form. To
facilitate plausibility checking, each variable was assigned a
probability range, encompassing the range of probable values for
that variable. In addition, a range of possible values (storage range)
for that variable was defined (e.g., for FiO2, no values <21% or
>100% could be accepted). Thus, formal plausibility controls in the
software systems were used wherever possible and ensured the
maximum of data quality checking during data collection.
Participants who could not use one of the two software options
were allowed to record the data on paper forms and submit them to
the CCC (n=26 ICUs). Patient data were then entered into the SAPS
3 stand-alone software system and thus checked for plausibility. In
cases of uncertainty, ICU coordinators were contacted for clarifi-
cation.
In addition, each ICU received a questionnaire with detailed
questions about ICU structures and about resources available in
other areas of the hospital.
Data were collected at ICU admission, on days 1, 2 and 3, and
on the last day of the ICU stay. Data from the day of admission
(aside from sociodemographic data such as age and sex) were
categorized into different levels: (i) data about the condition of the
patient before ICU admission, such as chronic conditions and
medical diseases; (ii) data about the patient’s condition at ICU
admission, such as the reason for admission, infection at admission,
and surgical status; and (iii) data about the patient’s physiologic
derangement at ICU admission. These data were collected within
an hour before or after ICU admission.
On the following days of the ICU stay, further information was
collected: severity of illness, as measured by the SAPS II [5];
number and severity of organ dysfunction, as measured by the
Sequential Organ Failure Assessment (SOFA) [28]; length of ICU
and hospital stay; and outcome data, including vital status at ICU
and hospital discharge. All patients were subjected to mandatory
follow-up until hospital discharge, but not longer than 90 days after
ICU admission. Patients still remaining in the hospital at 90 days
were at that time classified as being “still in the hospital”.
To record diagnoses, a three-level system was used. (i) An acute
medical disease was recorded for all patients, independent of sur-
gical status, i.e., the acute (or acute on chronic) disease that best
explained the ICU admission. If the reason for ICU admission was
infectious disease, then this was recorded. (ii) Surgical status at
admission and the anatomic site of surgery were recorded for all
patients undergoing surgery during the hospital stay before ICU
admission. (iii) A concrete reason for admission had to be selected.
At least one reason for admission was required, but several selec-
tions were possible (one within each organ system). If no other
reason was present, at least “basic and observational care” had to be
selected.
All participants received detailed documentation of patient- and
ICU-based data items as well as a detailed description of the data
collection process. Moreover, specific forms to check the com-
pleteness of the patient-based documentation were provided. Ad-
ditionally, a training session for ICU coordinators was organised at
the 15th Annual Congress of the ESICM in Barcelona, Spain, be-
fore the start of data collection. Throughout the project, the project
website (http://www.saps3.org) provided all necessary information.
In addition, the CCC was available to answer questions by email,
fax and phone. Data were to be collected from all consecutively
admitted patients between 14 October and 15 December 2002.
ICUs with a high number of beds (and thus also admissions) could
stop patient enrolment after contributing 100 patients.
Database
Data were collected and pooled by the CCC. The final database file
was then imported into the SAS system, Version 8e (SAS Institute
Inc., Cary, USA). Data cleaning was accomplished through the
application of a variety of additional plausibility controls and cross-
checking of information between redundant data fields.
A total of 22,791 admissions were recorded in the 309 partici-
pating ICUs during the study period. For patients who were ad-
mitted more than once (n=1,455), only the first admission was
included, giving 21,336 admitted patients. Patients who were
<16 years of age (n=628), those without ICU admission or dis-
charge data (n=1,074), and those with records that lacked an entry
in the field “ICU outcome” (n=57) were excluded. The Basic SAPS
3 Cohort thus comprises 19,577 patients from 307 ICUs.
For the development of a predictive model for hospital mortality
as outcome, patients with a missing entry in the field of “vital status
at hospital discharge” (n=2,540) or an entry of “still in the hospital”
at the end of the follow-up period (n=253) were further excluded.
The SAPS 3 Hospital Outcome Cohort thus comprises 16,784 pa-
tients from 303 ICUs.
Because the study was an observational study and no additional
interventions were performed, the need for informed consent was
waived by the institutional review board. Each ICU, however, was
made responsible for obtaining local permissions as necessary.
Data quality
Recorded data were evaluated for completeness of the documen-
tation and reliability. Interrater quality control was performed
through rescoring of the data from day 0 (the day of ICU admis-
sion) for three randomly selected patients in each ICU. From the
rescored data, kappa coefficients and intra-class correlation coef-
ficients were calculated, as appropriate. Availability of the vari-
ables necessary to calculate the SAPS II was used as an indicator
for the completeness of the data.
Statistical analysis
Statistical analysis was performed using the SAS system, version 8e
(SAS Institute Inc., Cary, NC, USA). A P value of <0.05 was
considered significant. Unless otherwise specified, results are ex-
pressed as median and interquartile ranges (quartile). Observed-to-
expected (O/E) mortality ratios were calculated by dividing the
number of observed deaths per group by the number of expected
deaths per group (as predicted by the SAPS II). To test for statis-
tical significance, we calculated 95% confidence intervals (CI)
according to the method described by Hosmer and Lemeshow [29].
The Hosmer-Lemeshow goodness-of-fit H ˆ-statistic and C ˆ-statistic
[30] were used to evaluate the calibration of the SAPS II. Dis-
crimination was tested by measuring the area under the receiver1339
operating characteristic (aROC) curve, as described by Hanley and
McNeil [31]. Reliability of data collection was analysed using K-
statistics or intra-class correlation coefficients, as appropriate.
Statistical methods used for the development of the predictive
model are described in Part 2 of this report.
Results
Data quality
Four hundred eighty-three rescored patients could be
identified and linked to their original counterparts (2.5%
of admitted patients). Data quality was found to be ex-
cellent, with the majority of coefficients being >0.85.
Only two of the more than 50 tested variables had coef-
ficients <0.80 (body weight, 0.79; positive end-expiratory
pressure, 0.72), and only one was <0.70 (leukocytes
[maximum], 0.57). For a detailed list of coefficients see
Table E1 in the ESM. Data completeness was also found
to be satisfactory, with 1 [0–3] SAPS II parameter mis-
sing per patient.
Description of ICUs
The Basic SAPS 3 cohort includes 307 ICUs from 35
countries. On average each ICU contributed 50 (27–78)
patients to the cohort. To assess heterogeneity of results
between different geographic regions, seven regions were
defined: Australasia, Central and South America, Central
and Western Europe, Eastern Europe, North America,
Northern Europe, and Southern Europe and Mediter-
ranean countries. The allocation of countries to these re-
gions can be seen from Table E10 of the ESM.
Seventy percent of the participating ICUs identified
themselves as mixed medical-surgical (Table E2, ESM).
Roughly half of the ICUs (46%) were located in univer-
sity-affiliated or teaching hospitals. Eighty-four percent
of ICUs (n=258) reported having a full-time medical di-
rector, and 272 (88.6%) reported having a full-time
nursing director. On weekdays, 76.6% of ICUs reported
having an intensivist available on the ICU 24 hours per
day, whereas 6.2% had an intensivist available in the
hospital. In 12.1% of ICUs, the intensivist was at home,
on-call, during the daytime. During weekends, this pro-
portion did not change much (74.3%, 5.5%, and 15.0% on
the ICU, in the hospital, and on-call, respectively). None
of the participating ICUs reported having no intensivists
available during night or weekend shifts.
Description of patients
The Basic SAPS 3 Cohort comprises 19,577 patients
admitted to participating ICUs during the study period.
More than 70% of patients were admitted from the same
hospital as the ICU, with operating rooms, emergency
departments and normal wards contributing most of the
patients (Table 1). Almost two thirds of the admissions
were classified as unplanned. The mean age of patients
was 60.0€17.7 years (Fig. 1), and 39.2% were female.
Comorbidities were recorded in 65% of admitted patients,
with arterial hypertension, chronic obstructive pulmonary
disease, and chronic heart failure being the most frequent
(Table E3, ESM).
Cardiovascular, respiratory and neurologic diseases
were the most frequent organ-specific reasons for ad-
mission (Table E4, ESM). The acute medical diseases
Table 1 ICU admission data for the two cohorts (Basic cohort:
SAPS 3 basic cohort; HO cohort: SAPS 3 Hospital Outcome Co-
hort; n: number of patients)
Basic cohort HO cohort
n % n %
Number of patients 19,577 16,784 100.0
Gender
Female 7,678 39.2 6,610 39.4
Male 11,881 60.7 10,161 60.5
Missing 18 0.1 13 0.1
Age, years
(median, quartiles)
63 49-74 64 49-74
Origin
Home 2,810 14.4 2,343 14.0
Same hospital 13,926 71.1 12,063 71.9
Chronic care facility 74 0.4 64 0.4
Public place 519 2.7 432 2.6
Other hospital 2,125 10.9 1,791 10.7
Other 80 0.4 59 0.4
Missing 43 0.2 32 0.2
Intra-hospital location
before ICU admission
Emergency room 5,419 27.7 4,630 27.6
Intermediate care unit/
High dependency unit
562 2.9 475 2.8
Operating room 7,537 38.5 6,449 38.4
Other 552 2.8 413 2.5
Other ICU 698 3.6 611 3.6
Recovery room 482 2.5 400 2.4
Ward 3,411 17.4 3,036 18.1
Missing 916 4.7 770 4.6
ICU admission status
Planned admission 6,750 34.5 5,598 33.4
Unplanned admission 12,338 63.0 10,801 64.4
Missing 489 2.5 385 2.3
Acute Infection
at ICU admission
No infection 15,254 77.9 12,968 77.3
Clinically improbable/
colonization
342 1.7 298 1.8
Clinically probable/
documented
2,761 14.1 2,422 14.4
Microbiologically
documented
1206 6.2 1,083 6.5
Missing 13 0.1 13 0.1
Surgical status
No surgical procedure 8,437 43.1 7,305 43.5
Scheduled surgery 6,800 34.7 5,700 34.0
Emergency surgery 3,321 17.0 2,930 17.5
Missing 1,019 5.2 849 5.11340
necessitating ICU admission included a broad spectrum of
diagnoses (Table E5, ESM). Approximately one half of
the patients underwent surgery before ICU admission,
with abdominal, cardiac and vascular surgery being the
most frequent procedures (Table E6, ESM).
Regarding discharge details (Table 2), it is notable that
a high percentage of patients were discharged unplanned
(8.15%), i.e., without at least a 12-hour planning window.
15.2% of patients from the SAPS 3 Basic cohort died
within the ICU. As can be seen from Table 3, patient
cohorts differed significantly between regions. Both, ICU
and hospital mortality rates exhibited a broad spectrum
between ICUs: hospital mortality was on average 28%
(17–42%) in the SAPS 3 Hospital outcome cohort.
Performance of the SAPS II
The performance of the original SAPS II model [5] (using
data from the first 24 hours) was tested in the SAPS 3
Hospital Outcome Cohort (n=16,784). Discrimination was
good with an aROC of 0.83 (95% CI: 0.824–0.838). SAPS
II showed underestimation of hospital mortality: The O/E
ratio of the overall cohort was 1.08 (1.06–1.10). O/E ra-
tios significantly differed between regions: from 0.86
(0.81–0.91) for Central and Western Europe to 1.32
(1.25–1.38) for Central and South America, with four out
of the seven defined regions exhibited O/E ratios signif-
icantly different from 1 (Table E7, ESM). Calibration, as
assessed by the Hosmer-Lemeshow H ˆ +C ˆ statistics, was
poor for the overall cohort: H ˆ 227.21, C ˆ 184.70; both
p<0.0001; This lack of calibration was present for all
tested subgroups except for the region of North America
(see Table E7, ESM).
Fig. 1 Age distribution and as-
sociated mortality. The figure
shows the age distribution of
the Basic SAPS 3 Cohort
(n=19,577) and the correspond-
ing ICU mortality rates for each
stratum. Columns: Number of
patients as percentages of the
whole cohort; squares: ICU
mortality rates for the corre-
sponding stratum
Table 2 ICU discharge and outcome data for the two cohorts
(Basic cohort: SAPS 3 basic cohort; HO cohort: SAPS 3 Hospital
Outcome Cohort; n: number of patients; ICU LOS: ICU length of
stay; IMCU/HDU: intermediate care unit/high dependency unit;
Q1, Q3: lower and upper interquartile range, respectively)
Basic cohort HO cohort
n % n %
Number of patients 19,577 100.0 16,784 100.0
ICU LOS, days
(median, quartiles)
2 1–6 2 1–6
ICU discharge–
destination
Home 438 2.2 361 2.2
Same hospital 14,946 76.3 12,477 74.3
Other hospital 1,029 5.3 852 5.1
Missing 3,164 16.2 3,094 18.4
Intrahospital discharge
Emergency room 58 0.3 50 0.3
IMCU/HDU 2,222 11.4 1,873 11.2
Other 303 1.5 257 1.5
Other ICU 583 3.0 479 2.9
Recovery room 306 1.6 218 1.3
Ward 12,250 62.6 10,291 61.3
Missing 3,855 19.7 3,616 21.5
ICU discharge—status
Planned discharge 14,872 76.0 12,262 73.1
Unplanned discharge 1,595 8.1 1,467 8.7
Missing 3,110 15.9 3,055 18.2
Risk adjustment
SAPS II score
(median, Q1–Q3)
30 20–42 31 21–43
SOFA score
(median, Q1–Q3)
9 6–11 9 6–11
Outcome
ICU mortality (%) 15.2 17.71341
Discussion
To the best of our knowledge, the SAPS 3 study is the
largest prospective epidemiologic multicentre, multina-
tional study conducted in health services and outcomes
research in intensive care medicine to date.
The project was first intended to focus on Europe be-
cause it was believed such a strategy would produce a
more homogeneous cohort of patients, which would in
turn provide a more stable reference line for further
comparisons. This idea was discussed during several in-
vestigator meetings and finally abandoned—first, because
interest from outside Europe was enormous: 39% of ICUs
that registered for the project were located outside Eu-
rope. The SAPS 3 board members thus agreed that such a
high level of interest should not be ignored. Second, some
investigators questioned whether a concentration on Eu-
ropean ICUs would be successful in reducing heteroge-
neity anyway. Provision of intensive care in Europe is
extremely variable, with enormous differences in severity
of illness, provision of treatments and mortality from
north to south and from west to east [32, 33].
For these reasons ICUs from regions outside Europe
were invited to participate. Our results prove that we were
right in our assumptions: First, one can easily see that the
four European regions (as defined in our study) are hardly
comparable: severity of illness as measured by the SAPS
II varied from 27 to 35 points, and ICU mortality ranged
from 10.8 to 20.6%—almost a doubling of mortality
figures (Table 3). Second, almost a third of the patient
cohort (28.5%) was contributed from regions outside
Europe.
Although the decision to accept ICUs worldwide
probably increased the heterogeneity of our sample, it
also allowed the SAPS 3 database to better reflect im-
portant differences in patients’ and health care systems’
baseline characteristics that are known to affect outcome.
These include, for example, different genetic makeups,
different styles of living or a heterogeneous distribution of
major diseases within different regions, as well as issues
such as access to the health care system in general and to
intensive care in particular, or differences in availability
and use of major diagnostic and therapeutic measures
within the ICUs [32, 34]. Although the integration of
ICUs outside Europe and the U.S. surely increased it’s
representativeness, it must be acknowledged, that the
extent to which the SAPS 3 database reflects case-mix on
ICUs worldwide cannot be determined yet.
It should additionally be noted that allocation of
countries to regions does not always follow geographic
borders (Table 3; see also Table E10 in the ESM). Par-
titioning of the sample was done to adjust for some of the
above-stated differences between different populations
and to develop a system that uses several different ref-
erence lines to compare ICUs on a similar level. Thus,
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patients are not necessarily representative of their re-
spective regions.
To minimize possible seasonal influences, we chose
late fall in the Northern Hemisphere for data collection.
Thus, participants in both late fall/winter (Northern
Hemisphere) and spring/summer (Southern Hemisphere)
are represented in our cohort. A recent study [35] showed,
moreover, that differences in seasonal mortality rates, at
least in a sample of ICUs in the United Kingdom, were
related to variations in case mix rather than to a specific
impact of season on outcome.
Performance of the SAPS II was, not surprisingly,
found to be similar to that in previous studies: acceptable
discrimination but lack of calibration. Possible reasons for
this have already been alluded to in the Introduction. In
contrast to previous studies, however, we found an un-
derestimation of hospital mortality, which contradicts the
rationale that the shifting in calibration is due only to the
development of new and possibly better therapies and
thus to better ICU performance [19].
Analyzing the various geographic regions provides
evidence that the underestimation of hospital mortality
by the SAPS II might be partially attributable to the
composition of the cohort: SAPS 3 is the first large in-
ternational study on severity of illness systems to include
patients from all continents. South America, for exam-
ple, where provision of intensive care is much more
limited than it is in Europe or North America, con-
tributed extensively to the patient cohort. High O/E ra-
tios have already been reported for this continent [36]
and are probably linked to the limited availability of
resources.
Data quality was one of our major concerns. Com-
pleteness of the documentation was found to be satis-
factory: The amount of missing data is in fact smaller than
reported from previous cohort studies on severity of ill-
ness systems [11, 12, 16]. With respect to reliability, in-
traclass-correlation coefficients and kappa coefficients
were generally similar to or even better than those found
in previous studies, showing a high degree of interrater
agreement (see Table E1 in ESM) [37, 38].
We did, however, experience problems with the cohort
of rescored patients: First, we had to exclude all rescored
patients for whom the original counterpart was also ex-
cluded due to the application of any of the exclusion
criteria. Second, in some cases the original patient iden-
tification was either missing or documented in such a way
that a unique allocation was not possible. Both of these
exclusions reduced the number of rescored patients
available for analysis.
Two strategies to build up a cohort are available: first,
to recruit only patients who meet well-documented in-
clusion criteria (such as documented vital status at hos-
pital discharge) or, second, to document all patients and
then exclude patients based on a predefined set of ex-
clusion criteria. For the SAPS 3 study we chose the sec-
ond option—to form two different cohorts—because we
needed to provide a basic cohort for all further analyses of
the SAPS 3 database. Since some studies will focus on
different outcomes (e.g., ICU outcome rather than hos-
pital outcome), we decided to use missing ICU outcome
(and not hospital outcome) as an exclusion criterion for
the basic cohort.
A possible limitation of the SAPS 3 database is that
vital status at hospital discharge was not available for all
admitted patients. Despite several efforts from the CCC
and sufficient time to allow for a close follow-up, we did
not succeed to receive all hospital outcomes document-
ed. Recording of hospital outcome (or later outcomes)
still poses major problems for ICUs in European and
non-European hospitals, either because of technical
problems or possibly because of data security algorithms
in the hospitals. Exclusion of these patients did, how-
ever, not affect major criteria, such as geographic rep-
resentation, ICU admission or discharge data, co-mor-
bidities, or the distribution of the reasons for admission
(Tables 1 and 2).
We conclude that the SAPS 3 database is within the
above discussed limits of high quality and reflects the
heterogeneity of current intensive care provision. As such,
it provides an excellent basis for the development of a
new risk adjustment system.
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